Meanwhile, human alpha-1-proteinase inhibitor (89), a potential targeting compound of SERPINA1, elicits a therapeutic effect on progressive ultimate fatal emphysema by inhibiting neutrophil elastase in the lung. This evidence concerns the gene SERPINA1 and pulmonary emphysema.